IFNL3 polymorphisms predict response to therapy in chronic hepatitis C genotype 2/3 infection.

Mohammed Eslam, Reynold Leung, Manuel Romero-Gomez, Alessandra Mangia, William L. Irving, David Sheridan, Ulrich Spengler, Lindsay Mollison, Wendy Cheng, Elisabetta Bugianesi, Duncan McLeod, Abed M. Zaitoun, Vito Attino, Diane Goeltz, Jacob Nattermann, Mark Douglas, David R. Booth, Jacob George*, Golo Ahlenstiel

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'IFNL3 polymorphisms predict response to therapy in chronic hepatitis C genotype 2/3 infection.'. Together they form a unique fingerprint.

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology

Neuroscience